Company Overview and News

American Axle (AXL) Rides on New Launches, Strategic Actions

2018-04-11 zacks
On Apr 10, we issued an updated research report on American Axle & Manufacturing Holdings, Inc. (AXL - Free Report) . American Axle is anticipated to attain record sales and profits in 2018. For the year, sales are expected to be around $7 billion compared with $6.27 billion recorded in 2017. In 2018, the company plans to support 50 major projects and program launches, including electric and hybrid driveline program.
Upvote Downvote

Dana: Potential Acquisition Of GKN Creates Automotive Juggernaut

2018-03-30 seekingalpha
A love triangle exists between Dana, Melrose, and GKN. Melrose has been engaging in a hostile takeover attempt of GKN for months.
Upvote Downvote

American Axle & Manufacturing (AXL) Presents At Bank Of America Merrill Lynch New York Auto Summit - Slideshow

2018-03-29 seekingalpha
The following slide deck was published by American Axle & Manufacturing Holdings, Inc. in conjunction with this event.
Upvote Downvote

RBC Says 5 Top Industrial Stocks Are Potential Takeover Candidates

2018-03-27 247wallst
It happens every year, and 2018 won’t be any different. Larger companies looking to add to growth, in addition to that of the organic or internal variety, scan the field for purchases and acquisitions that are easy to bolt on and could add returns in a timely fashion. This year the process may even speed up some as last month’s market sell-off may have already put some companies in the sights of acquirers.
Upvote Downvote

Top Analyst Upgrades and Downgrades: Albermarle, BB&T, Cheniere, Chesapeake Energy, Kinder Morgan, Red Hat, Roku and Many More

2018-03-27 247wallst
Stocks surged higher on Monday after it appears that the trade war risks may have been somewhat overblown. Stocks were indicated to open higher on Tuesday as well. The bull market is now over nine years old and the trend that has prevailed so far has been for investors to buy the pullbacks. Investors are still trying to decide how they want their allocations positioned for the rest of 2018 and beyond.
Upvote Downvote

Should Value Investors Pick American Axle & Manufacturing (AXL) Stock?

2018-03-26 zacks
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value?
Upvote Downvote

Stocks To Watch: Back To School For Apple

2018-03-24 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
Upvote Downvote

Top Analyst Upgrades and Downgrades: Booking Holdings, Borg Warner, Delphi, Pandora, Ralph Lauren, Southwest Airlines and More

2018-03-22 247wallst
The futures looked decidedly lower Thursday morning as the market digested the newest increase in the federal funds rate, which was announced Wednesday afternoon. While many feel that the Federal Reserve will only raise two more times this year, some may be focusing on Fed Chair Powell’s comment that some asset price are elevated. The one trend that has dominated this bull market is that investors keep finding new reasons to buy stocks after every single sell-off.
Upvote Downvote

American Axle (AXL) Down 5.8% Since Earnings Report: Can It Rebound?

2018-03-19 zacks
It has been about a month since the last earnings report for American Axle & Manufacturing Holdings, Inc. (AXL - Free Report) . Shares have lost about 5.8% in that time frame.
Upvote Downvote

AXL / American Axle & Manufacturing Holdings, Inc. 424B2 (Prospectus)

Use these links to rapidly review the document Table of Contents Prospectus Supplement TABLE OF CONTENTS
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 024061103